oxymorphone
FDA Joint Committee Votes Opana ER Risks Outweigh Benefits
Most of the panelists agreed that the drug should be removed from the market due to its high potential for IV ...
MARCH 29, 2017
Steep Rise in Rural Infants Born With Opioid Withdrawal
The number of infants born with drug withdrawal symptoms from opioids grew substantially faster in rural ...
MARCH 15, 2017
Load more